title: Baseline potency in candidates for bilateral nerve-sparing radical retropubic prostatectomy.
abstract: OBJECTIVE
  To assess the baseline erectile function (EF) of patients with clinically localized prostate cancer (pCa), who are candidates for a bilateral nerve-sparing radical retropubic prostatectomy (BNSRRP) to (a) objectively rate the preoperative self-reported subjective patient's EF and (b) investigate possible correlations between preoperative EF and demographic data and comorbidities.
  
  
  METHODS
  Two-hundred-thirty-four patients, who verbally self-reported they were preoperatively fully potent and strongly motivated to maintain postoperative EF, underwent a BNSRRP. A comprehensive medical and sexual history was obtained on hospital admission the day prior to surgery. Subjectively reported potency rate was compared with the scores of the International Index of Erectile Function (IIEF).
  
  
  RESULTS
  The EF domain of the IIEF showed a baseline normal EF in only 43% of the subjects. In contrast, 13% had a mild erectile dysfunction (ED), 8% had a mild to moderate ED, 8% complained of a moderate ED, and as many as 28% reported severe EF impairment. Interestingly, 38% of the patients with severe ED did not attempt any intercourse during the last 4 weeks prior to surgery.
  
  
  CONCLUSIONS
  A significant proportion of patients with clinically localized pCa and self-reported total potency already had suffered from ED preoperatively. Incorrect timing of questionnaires administration, the potential influence of preoperative patient's psychological distress, and the implication of the patient's partner's psychological and sexual health may be contributing factors to the contradictory finding. The preoperative use of validated questionnaire may help to identify patients who can actually expect to regain potency following a BNSRRP.
authors.affiliation: Department of Urology, University Vita-Salute San Raffaele, Scientific Institute H. San Raffaele, Milan, Italy. salonia.andrea@hsr,it
authors.forename: Andrea
authors.initials: A
authors.lastname: Salonia
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Zanni
authors.forename: Andrea
authors.initials: A
authors.lastname: Gallina
authors.forename: Antonino
authors.initials: A
authors.lastname: Saccà
authors.forename: Mattia
authors.initials: M
authors.lastname: Sangalli
authors.forename: Richard
authors.initials: R
authors.lastname: Naspro
authors.forename: Alberto
authors.initials: A
authors.lastname: Briganti
authors.forename: Elena
authors.initials: E
authors.lastname: Farina
authors.forename: Marco
authors.initials: M
authors.lastname: Roscigno
authors.forename: Luigi F
authors.initials: LF
authors.lastname: Dapozzo
authors.forename: Patrizio
authors.initials: P
authors.lastname: Rigatti
authors.forename: Francesco
authors.initials: F
authors.lastname: Montorsi
mesh_terms: D000328:Adult; D000704:Analysis of Variance; D007172:Erectile Dysfunction / Q000209:etiology* / Q000503:physiopathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D010410:Penile Erection; D011467:Prostate / Q000294:innervation* / Q000601:surgery*; D011468:Prostatectomy / Q000009:adverse effects / Q000379:methods*; D011471:Prostatic Neoplasms / Q000601:surgery*; D016896:Treatment Outcome